0143-9830-01 · Methotrexate Sodium Injection · Hikma Pharmaceuticals USA, Inc.
What is the status for 0143-9830-01 · Methotrexate Sodium Injection · Hikma Pharmaceuticals USA, Inc.?
For 0143-9830-01, generic name is Methotrexate Sodium Injection; manufacturer is Hikma Pharmaceuticals USA, Inc; status is Current; availability now is Unavailable; initial posting date is 03/13/2023, recorded from its source on 2026-11-04.
"initial_posting_date": "03/13/2023", "package_ndc": "0143-9830-01", "generic_name": "Methotrexate Sodium Injection", "contact_info": "800-631-2174", "availability": "Unavailable", "related_info": "Additional lots will be available in the November 2026 timeframe. Short Dated Prodcut Available."
— api.fda.gov, retrieved 2026-11-04
- Package NDC
- 0143-9830-01 verified
- Generic name
- Methotrexate Sodium Injection verified
- Manufacturer
- Hikma Pharmaceuticals USA, Inc. verified
- Status
- Current verified
- Availability now
- Unavailable verified
- FDA note
- Additional lots will be available in the November 2026 timeframe. Short Dated Prodcut Available. verified
- Initial posting date
- 03/13/2023 verified
- Last update date
- 10/14/2026 verified
- Days in shortage
- 1332 our reading
- Reason for shortage
- Demand increase for the drug verified
- Dosage form
- Injection verified
- Therapeutic category
- Rheumatology verified
Values marked our reading are our classification of what the source says — the source does not print them in those words. The quote below is the evidence for each one; judge it yourself.
Where each value comes from
The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.
Manufacturer, Status, Last update date, Reason for shortage, Dosage form and Therapeutic category
"update_date": "10/14/2026", "therapeutic_category": [ "Rheumatology", "Oncology" ], "dosage_form": "Injection", "presentation": "Methotrexate, Preservative Free, Injection, 1 g (NDC 0143-9830-01)", "company_name": "Hikma Pharmaceuticals USA, Inc.", "shortage_reason": "Demand increase for the drug", "status": "Current"
— all from api.fda.gov, retrieved 2026-11-04
Source
- api.fda.govhttps://api.fda.gov/drug/shortages.json?search=company_name%3A%22Hikma%20Pharmaceuticals%20USA,%20Inc.%22+AND+generic_name%3A%22Methotrexate%20Sodium%20Injection%22+AND+status%3A%22Current%22&limit=1000